The July Consumer Price Index (CPI) appears to progress towards the Federal Reserve’s 2% inflation target rate. Consumer prices have started cooling after rising a modest 2.9% in the 12 months through…
Holding a promising future due to recent success in the obesity drug market, Eli Lilly (NYSE:LLY) appears to be bound for continued gains. An impressive move higher in LLY stock, with the…
Chris MacDonald Long-term stocks, or those that are meant to be held for over a year, let investors ignore daily market fluctuations. Known as “sleep-at-night” stocks, they remain reliable in the face of volatility,…
Eli Lilly (NYSE: LLY | LLY Price Prediction) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity drugs. Shares have ballooned by nearly 60%…
Gerelyn Terzo Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
ETFs have become an exceptionally popular choice for investors seeking diversification and exposure to large market segments. Thematic ETFs, like the iShares S&P 500 Value ETF (NYSE: IVE), capture investor interest in…
Many investors choose to invest in ETFs or mutual funds, which provide immediate diversification. These versatile “baskets” of securities offer a convenient way to gain exposure to many different market segments at…
ETFs and mutual funds can both be powerful tools for investors seeking diversification. Both of these investment vehicles hold baskets of securities. When you purchase them, you’re also purchasing a small amount…
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are…
ETFs are a great way for investors to get instant diversification at a low cost. But with so many ETFs available, choosing the right one for your investment goals can be daunting.…
Imagine buying a stock for 24 cents, and one day opening your brokerage account to see eye-popping returns of 55,919%. Your stock is now worth $133. Sound like a fairy tale? It…
The pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key players that have more recently provided much…
Chris MacDonald 24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts’ forecasts and prospered accordingly. In 5 Years, Eli Lilly has gained +732…
In the movie The Social Network, there’s a scene where the investor Sean Parker is trying to sweet talk Mark Zuckerberg and says “A million dollars isn’t cool… You know what’s cool?” The answer: a…
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
